Make Medicines Affordable · Episode

A technical briefer sharing gaps and access priorities to ensure access to right diagnostics for Bundibugyo Ebola virus outbreak in DRC and Uganda.

Alors que des milliers de personnes fuyant la guerre au Soudan se réfugient dans l’est du Tchad, les équipes de Médecins Sans Frontières (MSF) font face à une double épidémie de rougeole et de méningi...

Lenacapavir, almost 100% effective at preventing HIV, is priced by Gilead at $28,200 and inaccessible to many in low-income countries plagued by the disease.

Lenacapavir, almost 100% effective at preventing HIV, is priced by Gilead at $28,200 and inaccessible to many in low-income countries plagued by the disease.

BOLSTERING NATIONAL SECURITY: Today, President Donald J. Trump imposed tariffs on patented pharmaceuticals and their ingredients under Section 232 of the

The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir.

MSF calls on Gilead for direct access to lenacapavir, as the current rollout falls far short of the needs.

Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger.

February 2026 | Now on Substack

Brazil’s Congress fast-tracks a bill allowing compulsory licensing of Mounjaro patents, raising key IP and public health considerations.

Join us for a book launch discussing the history, politics and prospective future of pharmaceutical markets.

This quality improvement study assesses the vulnerability of leading commercial large language models to invisible text injection manipulation in simulated medical peer review.

In the past few months, the US federal administration signaled the launch of a new project called TrumpRx that is intended to shake up the pharmaceutical marketplace, providing patients with cheaper d...

From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first of its kind analysis of the global supply chains of two key adju...

Image from here In a huge development concerning the Risdiplam litigation saga, a division bench of the Delhi High Court has rejected the appeal against the order refusing to grant an interim injun…

Unlike with medicines, and with a few exceptions, South Africa’s regulator does not assess whether diagnostic tests and other medical devices on the market are safe and work as they are supposed to. T...

On January 26th 2024, the International Court of Justice (ICJ) recognized plausible grounds for genocide being committed in Gaza by Israel. A hallmark of the violence has been unprecedented attacks on...

Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations Guidance for Industry

Lawyers for Monarez say she was ‘targeted’ for ‘protecting the public’ by not endorsing ‘unscientific’ orders

This cross-sectional study estimates the association of accessibility and reimbursement for diabetes technologies and insulin with glycemic control among children with type 1 diabetes using data from ...